Page results
-
The Pathogen Genomic Unit offers access to explore the clinical applications and interpretation of pathogen genomic data for patients with a variety of infections.
-
This page has been written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine. It is for patients who have been referred to the clinic.
-
Information about Cerebral AVM (Arterio Venous Malformation) Endovascular Treatment at the NHNN
-
The lung function unit is an integral part of the department of Thoracic Medicine, offering a wide range of physiological tests to both inpatients and clinic outpatients within the Trust, to help not only in the diagnoses of lung disorders, but also to assess the severity of these conditions.
-
The department of Thoracic Medicine at UCH has particular expertise in the management of patients with bronchiectasis and respiratory infections (including fungal disease, lung abscess and opportunistic infections).
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
This page provides an overview of the Ambulatory Care Service for adult patients.
File results
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment